2009 rank: 14
Age: 51
The health care giant's consumer division has been under fire for recalls, and McCoy's $22.5 billion unit had its own issues -- patent expirations and stalled drug launches. But the future looks bright: J&J has 11 new drug filings planned for the next three years - one of its deepest pipelines ever.
NEXT: Melanie Healey
Last updated September 30 2010: 2:47 PM ET